Our vision is to save your vision
You need Flash player 8+ and JavaScript enabled to view this video.
If you are seeing distortions, gray spots,
or blurriness in your vision, don't delay.
See your eye doctor.
It may be possible to reverse these
effects.
Early detection of AMD is crucial to
keeping your vision.
Get the right treatment for Wet AMD:
antiangiogenic therapy.
You need Flash player 8+ and JavaScript enabled to view this video.
You need Flash player 8+ and JavaScript enabled to view this video.
News
Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD After the American Society of Retinal Specialists (ASRS) shared a note with its membership warning of vision-threatening cases of occlusive retinal vasculitis of wet AMD drug Beovu, Novartis issued a ...
Read More > Following the Euopean Medicines Agency (EMA) human medicine’s committee recommendation in December, Beovu (brolucizumab) received formal approval by the European Commission … Source:
Read More > In latest calculations, researchers pooled data from 22 prevalence studies involving 55,323 people, aged, on average, between 60 and 81, and from four incidence studies across Europe … Sourc...
Read More > At EURETINA 2019 Congress, the Australia based company Ophthea reported data that OPT-302 reduced areas of neovascularization by 38% more and decreased scarring by 39% more, compared to Lucentis alone...
Read More > Analysis of data from a Phase 2 study of abicipar pegol (Anti-VEGF DARPin®) in neovascular, or “wet,” age-related macular degeneration (AMD) showed positive results, leading to the decision to ad...
Read More > The presence of vitreous separation may play a role in ranibizumab therapy for neovascular age-related macular degeneration, according to a poster presented at the Association for Research in Vision a...
Read More >
